在阿尔茨海默氏病中NOX4介导的天体细胞铁死
Yasenjiang Maimaiti1, Ting Su2, Zhanying Zhang2
1Gerontology Center, People's Hospital of Xinjiang Uygur Autonomous Region, No.91 Tianchi Road, Urumqi, Xinjiang, China. yarish@xjrmyy.com.
Cell & bioscience
|July 3, 2024
概括
在阿尔茨海默氏症 (AD) 中,NADPH氧化酶4 (NOX4) 通过促进铁亡,驱动铁介导的星体细胞死亡. 沉默NOX4改善了认知和减少了AD病理,突出了NOX4作为治疗点.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 涉及复杂的细胞机制,包括星球细胞功能障碍和细胞死亡.
- 铁的积累和铁亡与阿尔茨海默病的发病有关.
- NADPH氧化酶4 (NOX4) 在阿尔茨海默病中铁介导的星细胞死亡中的特定作用尚不清楚.
研究的目的:
- 为了研究NOX4在阿尔茨海默氏病中铁介导的天体细胞铁的作用.
- 探索NOX4作为阿尔茨海默病的潜在治疗点.
主要方法:
- 来自AD患者的单细胞RNA测序数据的分析.
- 识别和分析天体细胞标记基因和生物过程.
- 集成与AD相关的芯片数据与与ferroptosis相关的基因,专注于NOX4.
- 在体外和体内验证NOX4在天体细胞铁和AD中的作用.
主要成果:
- 在AD数据集中,星细胞标记基因被显著丰富.
- 在AD中,NOX4被确定为AD中的星体细胞内铁亡的关键参与者.
- 在体外和体内抑制NOX4减少了铁亡,改善了认知功能,降低了粉样蛋白-β (Aβ) 和酸化 (p-Tau) 水平,并改善了线粒体异常.
- 证实NOX4可以促进天体细胞铁亡.
结论:
- NOX4是阿尔茨海默氏病中铁诱导的天体细胞铁的关键媒介.
- 向NOX4为缓解AD进展和相关的神经退行症提供了一个有希望的治疗策略.
相关概念视频
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461


